Complete Revascularization, Risk Stratification, and AI-based Approach in Cardiology

Exploring the potential impact of complete revascularization on myocardial injury and the need for a subanalysis to determine its effect on blood transfusion and immune responses. Also discussing the ORFEM trial and its AI-based approach to assess fat attenuation as a risk marker, with the aim of changing therapy and increasing lipid-lowering prescriptions. Brief mention of the Rise and Stream Two trials.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app